Gastroprotective agent rebamipide induces cyclooxygenase-2 (COX-2) in gastric epithelial cells

Digestive Diseases and Sciences

Volumn 50, Issue SUPPL. 1, 2005, Pages

  Murata, Hiroaki ^a   Yabe, Yuki ^a   Tsuji, Shingo ^a   Tsujii, Masahiko ^a   Hai, Ying Fu ^a   Asahi, Kayoko ^a   Eguchi, Hiroshi ^a   Kawano, Sunao ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

COX 2; Gastric epithelial cells; Rebamipide; Reporter assay

Indexed keywords

GASTROINTESTINAL MUCOSA PROTECTIVE AGENT; PROSTAGLANDIN E2; REBAMIPIDE; ALANINE; ANTIULCER AGENT; CYCLOOXYGENASE 2; DRUG DERIVATIVE; PROSTAGLANDIN SYNTHASE; QUINOLONE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; MUCOSA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH MUCOSA; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; NEUTROPHIL; PHYSIOLOGY; WOUND HEALING;

ALANINE; ANIMALS; ANTI-ULCER AGENTS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC MUCOSA; GENE EXPRESSION REGULATION; NEUTROPHILS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; QUINOLONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; WOUND HEALING;

EID: 25644456769     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2809-0     Document Type: Article

References (29)

1. Robert A, Nazamis JE, Lancaster C, Davis JP, Field SO, Hanchar J: Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am J Physiol 245:G113-G121, 1983
2. Arakawa T, Nakamura A, Fukuda T, Higuchi K, Nakamura H, Kobayashi K: In vitro adaptive cytoprotection in gastric cells isolated from rat stomach. J Clin Gastoenterol 12(Suppl 1):S32-S38, 1990
3. Miller TA: Protective effects of prostaglandins against mucosal damage: current knowledge and proposed mechanism. Am J Physiol 245:G601-G623, 1983
4. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266:12866-12872, 1991
5. Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T: Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for posttranscriptional regulation. J Biol Chem 269:11769-11775, 1994
6. Sun WH, Tsuji S, Tsujii M, Gunawan ES, Sawaoka H, Kawai N, Iijima H, Kimura A, Kakiuchi Y, Yasumaru M, Sasaki Y, Kawano S, Hori M: Cyclooxygenase-2 inhibitors suppress epithelial cell kinetics and delay gastric wound healing in rats. J Gastroenterol Hepatol 15:752-761, 2000
7. Mizuno H, Sakamoto C, Matsuda K, Wada K, Uchida T, Noguchi H, Akamatsu T, Kasuga M: Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112:387-397, 1997
8. Watanabe T, Higuchi K, Hamaguchi M, Tanigawa T, Wada R, Tominaga K, Fujiwara Y, Arakawa T: Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils. Dig Dis Sci 47:1582-1589, 2002
9. Yamasaki K, Kanbe T, Chijiwa T, Ishiyama H, Morita S: Gastric mucosal protection by OPC-12759, a novel antiulcer compound in the rat. Eur J Pharmacol 142:23-29, 1987
10. Haruma K, Ito M: Clinical significance of mucosal-protective agents: acid, inflammation, carcinogenesis and rebamipide. Aliment Pharmacol Ther 18(Suppl 1):153-159, 2003
11. Fujioka T, Arakawa T, Shimoyama T, Yoshikawa T, Ito M, Asaka M, Ishii H, Kuwayama H, Sato R, Kawai S, Takemoto T, Kobayashi K: Effects of rebamipide, a gastro-protective drug on the Helicobacter pylori status and inflammation in the gastric mucosa of patients with gastric ulcer: a randomized double-blind placebo-controlled multicenter trial. Aliment Pharmacol Ther 18(Suppl 1):146-152, 2003
12. Arakawa T, Watanabe T, Fukuda T, Yamasaki K, Kobayashi K: Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. Dig Dis Sci 40:2469-2472, 1995
13. Kim CD, Hong KW: Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat. J Pharmacol Exp Ther 275:340-344, 1995
14. Watanabe S, Wang XE, Hirose M, Osada T, Tanaka H, Sato N: Rebamipide prevented delay of wound repair induced by hydrogen peroxide and suppressed apoptosis of gastric epithelial cells in vitro. Dig Dis Sci 43(Suppl):107S-112S, 1998
15. Yoshikawa T, Naito Y, Tanigawa T, Kondo M: Free radical scavenging activity of the novel anti-ulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung 43:363-366, 1993
16. Ogino K, Hobara T, Ishiyama H, Yamasaki K, Kobayashi H, Izumi Y, Oka S: Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol 212:9-13, 1992
17. Murakami K, Okajima K, Harada N, Isobe H, Okabe H: Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats. Dig Dis Sci 43(Suppl):139S-142S, 1998
18. Suzuki M, Miura S, Mori M, Kai A, Suzuki H, Fukumura D, Suematsu M, Tsuchiya M: Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants. Gut 35:1375-1378, 1994.
19. Udagawa A, Shiota G, Ichiba M, Murawaki Y: Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor. Scand J Gastroenterol 38:141-146, 2003
20. Inoue H, Tanabe T: Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells. Biochem Biophys Res Commun 244:143-148, 1998
21. Inoue H, Umesono K, Nishimori T, Hirata Y, Tanabe T: Glucocorticoid- mediated suppression of the promoter activity of the cyclooxygenase-2 gene is modulated by expression of its receptor in vascular endothelial cells. Biochem Biophys Res Commun 254:292-298, 1999
22. Tarnawski AS, Arakawa T, Kobayashi K: Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action? Dig Dis Sci 43(Suppl):90S-98S, 1998
23. Tarnawski AS, Chai J, Pai R, Chiou SK: Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action? Dig Dis Sci 49:202-209, 2004
24. Sasaki E, Tominaga K, Watanabe T, Fujiwara Y, Oshitani N, Matsumoto T, Higuchi K, Tarnawski AS, Arakawa T: COX-2 is essential for EGF induction of cell proliferation in gastric RGM1 cells. Dig Dis Sci 48:2257-2262, 2003
25. 2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med 8:289-293, 2002
26. Kim H, Seo JY, Kim KH: Inhibition of lipid peroxidation, NF-kappa B activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells. Dig Dis Sci 45:621-628, 2000
27. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716, 1998
28. 2 stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biochem Biophys Res Commun 286:923-928, 2001
29. Jones MK, Kawanaka H, Baatar D, Szabo IL, Tsugawa K, Pai R, Koh GY, Kim I, Sarfeh IJ, Tarnawski AS: Gene therapy for gastric ulcers with single local injection of naked DNA encoding VEGF and angiopoietin-1. Gastroenterology 121:1040-1047, 2001